INM
NASDAQ
CA
InMed Pharmaceuticals Inc. - Common Shares
$0.68
▲ +$0.01
(+1.19%)
Vol 23K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.0M
ROE
-85.9%
Margin
-171.1%
D/E
0.00
Beta
0.38
52W
$1–$8
Wall Street Consensus
8 analysts · Feb 20230
Strong Buy
0
Buy
3
Hold
4
Sell
1
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%
Next Report
May 11, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2026 | — | — | — |
| Sep 2025 | — | $-1.94 | — |
| Jun 2024 | — | $-0.19 | — |
| Mar 2024 | — | $-0.76 | — |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $1.1M | $1.3M | $1.3M | $1.1M | $820K |
| Net Income | — | -$2.6M | -$2.1M | -$1.8M | -$1.7M | -$2.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -93.2% | -107.9% | -93.2% | -93.2% | -85.9% | -85.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -137.1% | -168.9% | -165.1% | -165.1% | -171.1% | -171.1% |
| Gross Margin | 44.2% | 32.4% | 34.5% | 34.5% | 33.7% | 33.7% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.99 | 3.49 | 6.99 | 6.99 | 6.95 | 6.95 |
Key Ratios
ROA (TTM)
-70.3%
P/S (TTM)
0.62
P/B
0.3
EPS (TTM)
$-7.21
CF/Share
$-2.20
Rev Growth 3Y
+65.5%
52W High
$8.27
52W Low
$1.13
$1.13
52-Week Range
$8.27
Financial Health
Free Cash Flow
-$2.4M
Net Debt
-$6.4M
Cash
$7.0M
Total Debt
$532K
As of Dec 31, 2025
How does INM compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
INM valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.6
▼
87%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
0.3
▼
86%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
INM profitability vs Pharmaceuticals peers
ROE
-85.9%
▼
58%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-171.1%
▼
261%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
33.7%
▼
51%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-70.3%
▼
88%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
INM financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
7.0
▲
107%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
0.4
▼
59%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
INM fundamentals radar
INM
Peer median
Industry
INM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
INM vs peers: key metrics
Top Holders
Top 5: 7.78%Sabby Management, LLC
6.91%
$127K
Susquehanna International G…
0.44%
$8K
Jane Street Group, LLC
0.41%
$8K
UBS Group AG
0.01%
$237
SBI Securities Co., Ltd.
0.01%
$188
As of Dec 31, 2025
Latest News
Dave & Buster's Entertainment, Inc. Q4 2026 Earnings Call Summary
Yahoo Finance · Apr 02
Live Nation Entertainment (LYV) Shares Cross Below 200 DMA
Nasdaq · Mar 26
DraftKings and Penn Entertainment Are Climbing Today: Is the Sports Betting Sector …
Yahoo Finance · Mar 25
Disney Missed Out on Monday's Market Rally. Is It a Red Flag …
Nasdaq · Mar 24
Why Tencent Music Entertainment Plunged Almost 30% This Week
Yahoo Finance · Mar 22